BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28065471)

  • 1. Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa.
    Van Damme T; Gardeitchik T; Mohamed M; Guerrero-Castillo S; Freisinger P; Guillemyn B; Kariminejad A; Dalloyaux D; van Kraaij S; Lefeber DJ; Syx D; Steyaert W; De Rycke R; Hoischen A; Kamsteeg EJ; Wong SY; van Scherpenzeel M; Jamali P; Brandt U; Nijtmans L; Korenke GC; Chung BHY; Mak CCY; Hausser I; Kornak U; Fischer-Zirnsak B; Strom TM; Meitinger T; Alanay Y; Utine GE; Leung PKC; Ghaderi-Sohi S; Coucke P; Symoens S; De Paepe A; Thiel C; Haack TB; Malfait F; Morava E; Callewaert B; Wevers RA
    Am J Hum Genet; 2017 Feb; 100(2):216-227. PubMed ID: 28065471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the clinical and molecular spectrum of ATP6V1A related metabolic cutis laxa.
    Vogt G; El Choubassi N; Herczegfalvi Á; Kölbel H; Lekaj A; Schara U; Holtgrewe M; Krause S; Horvath R; Schuelke M; Hübner C; Mundlos S; Roos A; Lochmüller H; Karcagi V; Kornak U; Fischer-Zirnsak B
    J Inherit Metab Dis; 2021 Jul; 44(4):972-986. PubMed ID: 33320377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase
    Esmail S; Kartner N; Yao Y; Kim JW; Reithmeier RAF; Manolson MF
    J Biol Chem; 2018 Feb; 293(8):2787-2800. PubMed ID: 29311258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2.
    Kornak U; Reynders E; Dimopoulou A; van Reeuwijk J; Fischer B; Rajab A; Budde B; Nürnberg P; Foulquier F; ; Lefeber D; Urban Z; Gruenewald S; Annaert W; Brunner HG; van Bokhoven H; Wevers R; Morava E; Matthijs G; Van Maldergem L; Mundlos S
    Nat Genet; 2008 Jan; 40(1):32-4. PubMed ID: 18157129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of ATP6V0A2-related autosomal recessive cutis laxa.
    Fischer B; Dimopoulou A; Egerer J; Gardeitchik T; Kidd A; Jost D; Kayserili H; Alanay Y; Tantcheva-Poor I; Mangold E; Daumer-Haas C; Phadke S; Peirano RI; Heusel J; Desphande C; Gupta N; Nanda A; Felix E; Berry-Kravis E; Kabra M; Wevers RA; van Maldergem L; Mundlos S; Morava E; Kornak U
    Hum Genet; 2012 Nov; 131(11):1761-73. PubMed ID: 22773132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolar H+-ATPase meets glycosylation in patients with cutis laxa.
    Guillard M; Dimopoulou A; Fischer B; Morava E; Lefeber DJ; Kornak U; Wevers RA
    Biochim Biophys Acta; 2009 Sep; 1792(9):903-14. PubMed ID: 19171192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival.
    Hucthagowder V; Morava E; Kornak U; Lefeber DJ; Fischer B; Dimopoulou A; Aldinger A; Choi J; Davis EC; Abuelo DN; Adamowicz M; Al-Aama J; Basel-Vanagaite L; Fernandez B; Greally MT; Gillessen-Kaesbach G; Kayserili H; Lemyre E; Tekin M; Türkmen S; Tuysuz B; Yüksel-Konuk B; Mundlos S; Van Maldergem L; Wevers RA; Urban Z
    Hum Mol Genet; 2009 Jun; 18(12):2149-65. PubMed ID: 19321599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel defect in phosphatidylinositol 4-kinase type 2-alpha (PI4K2A) at the membrane-enzyme interface is associated with metabolic cutis laxa.
    Mohamed M; Gardeitchik T; Balasubramaniam S; Guerrero-Castillo S; Dalloyaux D; van Kraaij S; Venselaar H; Hoischen A; Urban Z; Brandt U; Al-Shawi R; Simons JP; Frison M; Ngu LH; Callewaert B; Spelbrink H; Kallemeijn WW; Aerts JMFG; Waugh MG; Morava E; Wevers RA
    J Inherit Metab Dis; 2020 Nov; 43(6):1382-1391. PubMed ID: 32418222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the X-linked
    Rujano MA; Cannata Serio M; Panasyuk G; Péanne R; Reunert J; Rymen D; Hauser V; Park JH; Freisinger P; Souche E; Guida MC; Maier EM; Wada Y; Jäger S; Krogan NJ; Kretz O; Nobre S; Garcia P; Quelhas D; Bird TD; Raskind WH; Schwake M; Duvet S; Foulquier F; Matthijs G; Marquardt T; Simons M
    J Exp Med; 2017 Dec; 214(12):3707-3729. PubMed ID: 29127204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: the biochemical characteristics.
    Wopereis S; Morava E; Grünewald S; Mills PB; Winchester BG; Clayton P; Coucke P; Huijben KM; Wevers RA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):156-64. PubMed ID: 15955459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Human Mutation K237_V238del in a Putative Lipid Binding Motif within the V-ATPase a2 Isoform Suggests a Molecular Mechanism Underlying Cutis Laxa.
    Chu A; Yao Y; Glibowicka M; Deber CM; Manolson MF
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal recessive cutis laxa syndrome revisited.
    Morava E; Guillard M; Lefeber DJ; Wevers RA
    Eur J Hum Genet; 2009 Sep; 17(9):1099-110. PubMed ID: 19401719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Delineation of Cutis Laxa Syndromes: Paradigms for Homeostasis.
    Beyens A; Pottie L; Sips P; Callewaert B
    Adv Exp Med Biol; 2021; 1348():273-309. PubMed ID: 34807425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective protein glycosylation in patients with cutis laxa syndrome.
    Morava E; Wopereis S; Coucke P; Gillessen-Kaesbach G; Voit T; Smeitink J; Wevers R; Grünewald S
    Eur J Hum Genet; 2005 Apr; 13(4):414-21. PubMed ID: 15657616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of clinical and molecular variability in autosomal recessive cutis laxa 2A.
    Morlino S; Nardella G; Castellana S; Micale L; Copetti M; Fusco C; Castori M
    Am J Med Genet A; 2021 Mar; 185(3):955-965. PubMed ID: 33369135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent De Novo Mutations Affecting Residue Arg138 of Pyrroline-5-Carboxylate Synthase Cause a Progeroid Form of Autosomal-Dominant Cutis Laxa.
    Fischer-Zirnsak B; Escande-Beillard N; Ganesh J; Tan YX; Al Bughaili M; Lin AE; Sahai I; Bahena P; Reichert SL; Loh A; Wright GD; Liu J; Rahikkala E; Pivnick EK; Choudhri AF; Krüger U; Zemojtel T; van Ravenswaaij-Arts C; Mostafavi R; Stolte-Dijkstra I; Symoens S; Pajunen L; Al-Gazali L; Meierhofer D; Robinson PN; Mundlos S; Villarroel CE; Byers P; Masri A; Robertson SP; Schwarze U; Callewaert B; Reversade B; Kornak U
    Am J Hum Genet; 2015 Sep; 97(3):483-92. PubMed ID: 26320891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of zebrafish atp6v1e1b, encoding a subunit of vacuolar ATPase, recapitulates human ARCL type 2C syndrome and identifies multiple pathobiological signatures.
    Pottie L; Van Gool W; Vanhooydonck M; Hanisch FG; Goeminne G; Rajkovic A; Coucke P; Sips P; Callewaert B
    PLoS Genet; 2021 Jun; 17(6):e1009603. PubMed ID: 34143769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel homozygous variants of ATP6V0A2 and ALDH18A1 lead to autosomal recessive cutis laxa type 2 and 3 in two Pakistani families.
    Zaman Q; Iftikhar A; Rehman G; Khan Q; Najumuddin ; Jan A; Khan J; Anas M; Laiba ; Umair M; Muthaffar OY; Abdulkareem AA; Bibi F; Naseer MI; Jelani M
    J Gene Med; 2023 Oct; 25(10):e3522. PubMed ID: 37119015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the phenotype of metabolic cutis laxa with an additional disorder of N-linked protein glycosylation.
    Witters P; Breckpot J; Foulquier F; Preston G; Jaeken J; Morava E
    Eur J Hum Genet; 2018 May; 26(5):618-621. PubMed ID: 29192153
    [No Abstract]   [Full Text] [Related]  

  • 20. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa.
    Loeys B; Van Maldergem L; Mortier G; Coucke P; Gerniers S; Naeyaert JM; De Paepe A
    Hum Mol Genet; 2002 Sep; 11(18):2113-8. PubMed ID: 12189163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.